BioCentury
ARTICLE | Financial News

Inventiva completes IPO

February 17, 2017 7:53 PM UTC

Cancer, fibrosis and autoimmune company Inventiva S.A. (Euronext:IVA) raised €48 million ($51.2 million) through the sale of 5.7 million shares at €8.50 in an IPO underwritten by Société Générale and...

BCIQ Company Profiles

Inventiva S.A.